BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32205288)

  • 21. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
    Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
    Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
    Tamandjou Tchuem CR; Andersson MI; Wiysonge CS; Mufenda J; Preiser W; Cleary S
    Vaccine; 2021 May; 39(23):3141-3151. PubMed ID: 33962836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries.
    Li W; Jia L; Zhao X; Wu X; Tang H
    BMC Gastroenterol; 2018 Aug; 18(1):121. PubMed ID: 30071845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge].
    Yin XR; Liu ZH; Liu ZH; Li J; Zhuang H; Dou XG; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):262-265. PubMed ID: 29996336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree.
    Yang N; Lei L; Meng Y; Zhou N; Shi L; Hu M
    Front Public Health; 2022; 10():662442. PubMed ID: 35801242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
    Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
    J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes.
    Samadi Kochaksaraei G; Shaheen AA; Seow CH; Barkema HW; Coffin CS
    Liver Int; 2022 Aug; 42(8):1712-1730. PubMed ID: 35312156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 29. Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.
    van Schalkwyk J; Nourmoussavi M; Massey A; Gustafson R; Brodkin E; Petric M; Krajden M; Dobson S; Buxton J; Bigham M; Pick N; Schreiber R; Sherlock CH; Money D; Yoshida EM
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):525-8. PubMed ID: 25390612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
    Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation.
    Bierhoff M; Rijken MJ; Yotyingaphiram W; Pimanpanarak M; van Vugt M; Angkurawaranon C; Nosten F; Ehrhardt S; Thio CL; McGready R
    Int J Equity Health; 2020 Sep; 19(1):156. PubMed ID: 32912268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Decision tree and cost-benefit analysis on strategies related to preventing maternal-infantile transmission of hepatitis B virus infection].
    Shi G; Zhang SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):273-8. PubMed ID: 23759236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast feeding and immunoprophylaxis efficacy of mother-to-child transmission of hepatitis B virus.
    Zhang L; Gui X; Fan J; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Tong Y; Kong X; Ye P; Zong L
    J Matern Fetal Neonatal Med; 2014 Jan; 27(2):182-6. PubMed ID: 23682864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis.
    Li Y; Wang J; Yu Y; Qiu C; Li Z; Ling Q; Zhang G; Li L; Gong Y; Lu Q; Cao L; Gu T; Wang X; Zhang M; Zhang Q; Zhang H; Xu B; Shao L; Pu Y; Zhang W
    Liver Int; 2020 Oct; 40(10):2377-2384. PubMed ID: 32304160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
    Sun PP; Zhang SX; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of vertical transmission of hepatitis B: an observational study.
    Kubo A; Shlager L; Marks AR; Lakritz D; Beaumont C; Gabellini K; Corley DA
    Ann Intern Med; 2014 Jun; 160(12):828-35. PubMed ID: 24862434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
    Nayagam S; de Villiers MJ; Shimakawa Y; Lemoine M; Thursz MR; Walsh N; Hallett TB
    Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):635-645. PubMed ID: 37150181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994.
    Noto H; Terao T; Ryou S; Hirose Y; Yoshida T; Ookubo H; Mito H; Yoshizawa H;
    J Gastroenterol Hepatol; 2003 Aug; 18(8):943-9. PubMed ID: 12859724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.